• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

持续皮下胰岛素输注与注射治疗:在普通糖尿病门诊条件下的一项随机交叉试验。

Continuous subcutaneous insulin infusion versus injection therapy: a randomized cross-over trial under usual diabetic clinic conditions.

作者信息

Marshall S M, Home P D, Taylor R, Alberti K G

机构信息

Department of Medicine, New Medical School, Newcastle upon Tyne, UK.

出版信息

Diabet Med. 1987 Nov-Dec;4(6):521-5. doi: 10.1111/j.1464-5491.1987.tb00922.x.

DOI:10.1111/j.1464-5491.1987.tb00922.x
PMID:2962807
Abstract

Twelve C-peptide negative insulin-dependent diabetic patients participated in a randomized cross-over study of 6 months treatment with twice or thrice daily insulin injection therapy and continuous subcutaneous insulin infusion (CSII). Standard, non-intensified management conditions were maintained throughout. Glycosylated haemoglobin levels were similar on both regimens (9.2 +/- 0.5% versus 9.0 +/- 0.4%; CSII vs injection therapy; (mean +/- SEM). Capillary blood glucose concentrations before breakfast (5.2 +/- 0.4 mmol/l vs 9.1 +/- 0.8 mmol/l), after lunch (6.5 mmol/l +/- 0.8 vs 7.9 +/- 1.0 mmol/l) and before the evening meal (5.0 +/- 0.7 mmol/l vs 7.7 +/- 0.7 mmol/l) were lower on CSII, as were 24-hour urine glucose excretion and total insulin dose (39.3 +/- 2.2 vs 49.8 +/- 4.0 U/day). There was a significant positive correlation between fasting blood glucose values and glycosylated haemoglobin on injection but not pump treatment. Thus although blood glucose control at some individual daytime points appeared lower on CSII, overall diabetic control was similar on the two regimens.

摘要

12名C肽阴性胰岛素依赖型糖尿病患者参与了一项为期6个月的随机交叉研究,该研究对比了每日两次或三次胰岛素注射疗法与持续皮下胰岛素输注(CSII)对患者的治疗效果。研究全程保持标准的、非强化管理条件。两种治疗方案下糖化血红蛋白水平相似(分别为9.2±0.5%和9.0±0.4%;CSII组与注射治疗组;均值±标准误)。CSII组早餐前毛细血管血糖浓度(5.2±0.4 mmol/l对比9.1±0.8 mmol/l)、午餐后(6.5±0.8 mmol/l对比7.9±1.0 mmol/l)以及晚餐前(5.0±0.7 mmol/l对比7.7±0.7 mmol/l)均较低,24小时尿糖排泄量和胰岛素总剂量也较低(分别为39.3±2.2对比49.8±4.0 U/天)。注射治疗时空腹血糖值与糖化血红蛋白之间存在显著正相关,而泵治疗时则不存在。因此,尽管CSII在某些个体日间时间点的血糖控制似乎较低,但两种治疗方案的总体糖尿病控制效果相似。

相似文献

1
Continuous subcutaneous insulin infusion versus injection therapy: a randomized cross-over trial under usual diabetic clinic conditions.持续皮下胰岛素输注与注射治疗:在普通糖尿病门诊条件下的一项随机交叉试验。
Diabet Med. 1987 Nov-Dec;4(6):521-5. doi: 10.1111/j.1464-5491.1987.tb00922.x.
2
A crossover comparison of continuous insulin infusion and conventional injection treatment of type I diabetes.
Acta Med Scand. 1987;221(4):385-93. doi: 10.1111/j.0954-6820.1987.tb03360.x.
3
Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.在强化治疗的1型糖尿病患者中使用赖脯胰岛素比较持续皮下胰岛素输注和每日多次注射方案:一项随机研究。糖尿病泵治疗发展研究组。
Diabetes Care. 2000 Sep;23(9):1232-5. doi: 10.2337/diacare.23.9.1232.
4
Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.1 型糖尿病诊断时采用连续皮下胰岛素输注与多次皮下注射胰岛素治疗儿童和青少年:SCIPI RCT。
Health Technol Assess. 2018 Aug;22(42):1-112. doi: 10.3310/hta22420.
5
A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: improved control with CSII.
Diabetes Care. 1982 Sep-Oct;5(5):466-71. doi: 10.2337/diacare.5.5.466.
6
Human regular U-500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: The VIVID study.成人 2 型糖尿病患者经持续皮下胰岛素输注与多次皮下胰岛素注射给予人常规 U-500 胰岛素:VIVID 研究。
Diabetes Obes Metab. 2020 Mar;22(3):434-441. doi: 10.1111/dom.13947. Epub 2020 Jan 26.
7
Basal insulin substitution with glargine or continuous subcutaneous insulin infusion in adult type 1 diabetes patients-a randomized controlled trial.甘精胰岛素或持续皮下胰岛素输注替代基础胰岛素治疗成人 1 型糖尿病患者的随机对照试验。
Diabetes Technol Ther. 2010 Sep;12(9):689-93. doi: 10.1089/dia.2010.0062.
8
Comparison between continuous subcutaneous insulin infusion and multiple injections of insulin. A one-year prospective study.
Diabetes. 1982 Mar;31(3):255-64. doi: 10.2337/diab.31.3.255.
9
Metabolic effects of continuous subcutaneous insulin infusion: evidence that a rise and fall of portal vein insulin concentration with each major meal facilitates post-absorptive glycemic control.
Clin Invest Med. 1988 Jun;11(3):167-86.
10
Continuous subcutaneous insulin infusion (CSII) versus conventional injection therapy in newly diagnosed diabetic children: two-year follow-up of a randomized, prospective trial.
Diabet Med. 1989 Dec;6(9):766-71. doi: 10.1111/j.1464-5491.1989.tb01276.x.

引用本文的文献

1
Differences in Glycemic Control for Inpatients with Type 1 Diabetes on Insulin Pump Versus Subcutaneous Insulin Therapy.1 型糖尿病患者使用胰岛素泵与皮下胰岛素治疗的血糖控制差异。
J Gen Intern Med. 2024 Aug;39(10):1895-1900. doi: 10.1007/s11606-024-08736-4. Epub 2024 Apr 8.
2
Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials.1型糖尿病患者持续皮下胰岛素输注与强化胰岛素注射血糖控制效果比较:随机对照试验的荟萃分析
BMJ. 2002 Mar 23;324(7339):705. doi: 10.1136/bmj.324.7339.705.
3
How to achieve optimal diabetic control in patients with insulin-dependent diabetes.
如何在胰岛素依赖型糖尿病患者中实现最佳血糖控制。
Postgrad Med J. 1994 Oct;70(828):675-81. doi: 10.1136/pgmj.70.828.675.
4
Management of diabetes mellitus.糖尿病的管理
Arch Dis Child. 1989 Apr;64(4):622-8. doi: 10.1136/adc.64.4.622.
5
Insulin.胰岛素
BMJ. 1990 Mar 17;300(6726):731-6. doi: 10.1136/bmj.300.6726.731.
6
Recent developments in insulin delivery techniques. Current status and future potential.胰岛素给药技术的最新进展。现状与未来潜力。
Drugs. 1991 Aug;42(2):213-27. doi: 10.2165/00003495-199142020-00004.